Slow-SPEED: Can a smartphone app help people with prodromal Parkinson's stay more active?
Official title: Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Run by Radboud University Medical Center · NCT06993142 · Data updated 2026-11-12
This trial tests whether a remote smartphone app can help people with a LRRK2 G2019S or GBA1 N370S mutation increase daily activity and see if exercise might slow prodromal Parkinson's signs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 2 sites (Rochester, New York and 1 other locations) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | June 30, 2029 |
| Study ends | June 30, 2029 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT06993142 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 50 years or older with a confirmed LRRK2 G2019S or GBA1 N370S mutation who can walk indoors, use a compatible smartphone, and are not highly physically active at baseline.
✕Probably not a fit
Individuals without the specified genetic mutations or those unable to engage in long-term smartphone-guided activity may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with LRRK2 G2019S or GBA1 N370S mutations will use a mobile app to gradually increase daily steps and exercise time at a target heart rate over up to 36 months. The study collects digital biomarkers to form a prodromal load score, aiming to gauge changes in motor and non-motor prodromal features. Primary goals include long-term feasibility of remote, app-driven exercise and preliminary signals of effect on prodromal progression. The trial is conducted across multiple centers, leveraging a fully remote intervention with in-home activity monitoring. Eligibility requires genetic confirmation, adequate smartphone access, and ability to walk independently indoors.
Why it matters
Potential benefit: If successful, participants could experience increased physical activity with a potentially slower prodromal progression of Parkinson's disease.
How similar studies have gone: Prior studies using remote, app-based activity support have shown feasibility and positive signals for increasing activity, though this exact long-term, prodromal-focused approach is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria 1. previously identified LRRK2 G2019S or GBA N370S variant based on genotyping 2. aged 50 years or older 3. able to understand the English language 4. being able to walk independently inside the home without the use of a walking aid 5. in possession of a suitable smartphone (screen size minimum 4.6 inch), (Android version 9 or iOS version 15 or newer) 6. Not in a high physical activity range during the 4-week eligibility and baseline period Exclusion criteria 1. clinically diagnosed or self-reported diagnosis neurodegenerative disease 2. self-reported falls of three or more per year 3. dexterity problems or cognitive impairments hampering smartphone use 4. if they are not aware of and do not wish to be informed about an increased risk of developing diseases associated with the LRRK2 or GBA1 risk variant 5. if individual is not community-dwelling 6. in possession of one of the following devices: Huawei P8 Lite; Huawei P9 Lite; Xiaomi Mi 6; Huawei P20 Lite (Fitbit is incompatible)
Where it's running
-
University of Rochester Center for Health and Technology (CHeT)
Rochester, New York, United States Recruiting -
Radboud University Medical Center
Nijmegen, Gelderland, Netherlands Not yet recruiting
Study contacts
- Principal investigator: Sirwan KL Darweesh, PhD — Radboudumc Department of Neurology
- Study coordinator: Thomas Oosterhof, MSc
- Email: thomas.oosterhof@radboudumc.nl
- Phone: 0031631647857
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Increasing daily physical activity to slow cognitive decline in alpha-synuclein disorders
This study will test whether using a motivational smartphone app to increase everyday physical activity can help slow cognitive decline in people aged 50–80 with isolated REM sleep behavior disorder (an early sign of alpha‑synuclein disease).
-
Increasing physical activity in patients at risk of Parkinson's disease using a smartphone app
This study is testing a smartphone app to help people at risk of Parkinson's disease increase their physical activity and exercise intensity over two years.
-
Axial and cognitive symptoms and biomarkers in brain‑first versus body‑first Parkinson's disease
This project will test whether clinical exams, sleep testing, heart and brain scans, and blood/CSF biomarkers can distinguish brain‑first from body‑first early Parkinson's patients and predict worsening of balance and thinking problems.
-
Evaluating a new treatment for cognitive function in mild Alzheimer's dementia
This study is testing a new treatment that combines brain stimulation and cognitive training to see if it can help people with mild Alzheimer's dementia improve their thinking skills.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Virtual reality plus bilateral brain stimulation to improve arm and hand recovery after stroke
We will try combining virtual reality exercises with bilateral transcranial direct current stimulation (bi‑tDCS) to improve arm and hand movement in adults at least three months after a unilateral stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.